Search: onr:"swepub:oai:DiVA.org:uu-520215" >
Were cancer patient...
-
Johansson, Anna L., VKarolinska Institutet,Canc Registry Norway, POB 5313 Majorstuen, N-0304 Oslo, Norway.;Karolinska Inst, Dept Med Epidemiol & Biostat, POB 281, SE-17177 Stockholm, Sweden.
(author)
Were cancer patients worse off than the general population during the COVID-19 pandemic? : A population-based study from Norway, Denmark and Iceland during the pre-vaccination era
- Article/chapterEnglish2023
Publisher, publication year, extent ...
-
Elsevier,2023
-
electronicrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:uu-520215
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-520215URI
-
https://doi.org/10.1016/j.lanepe.2023.100680DOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:154350797URI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
Background In a population-based setting, we investigated the risks of testing positive for SARS-CoV-2 and developing severe COVID-19 outcomes among cancer patients compared with the general population.Methods In nationwide cohorts, we identified all individuals in Norway, Denmark and Iceland who tested positive for SARS-CoV-2 or had a severe COVID-19 outcome (hospitalisation, intensive care, and death) from March until December 2020, using data from national health registries. We estimated standardised incidence ratios (SIRs) with 95% confidence intervals (CIs) comparing cancer patients with the general population.Findings During the first wave of the pandemic, cancer patients in Norway and Denmark had higher risks of testing SARS-CoV-2 positive compared to the general population. Throughout 2020, recently treated cancer patients were more likely to test SARS-CoV-2 positive. In Iceland, cancer patients experienced no increased risk of testing positive. The risk of COVID-19-related hospitalisation was higher among cancer patients diagnosed within one year of hospitalisation (Norway: SIR = 2.43, 95% CI 1.89-3.09; Denmark: 2.23, 1.96-2.54) and within five years (Norway: 1.58, 1.35-1.83; Denmark: 1.54, 1.42-1.66). Risks were higher in recently treated cancer patients and in those diagnosed with haematologic malignancies, colorectal or lung cancer. Risks of COVID-19-related intensive care and death were higher among cancer patients. Interpretation Cancer patients were at increased risk of testing positive for SARS-CoV-2 during the first pandemic wave when testing availability was limited, while relative risks of severe COVID-19 outcomes remained increased in cancer patients throughout 2020. Recent cancer treatment and haematologic malignancy were the strongest risk factors.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Skog, AnnaCanc Registry Norway, POB 5313 Majorstuen, N-0304 Oslo, Norway.
(author)
-
Johannesen, Tom BorgeCanc Registry Norway, POB 5313 Majorstuen, N-0304 Oslo, Norway.
(author)
-
Myklebust, Tor ageCanc Registry Norway, POB 5313 Majorstuen, N-0304 Oslo, Norway.;More & Romsdal Hosp Trust, Dept Res & Innovat, Alesund, Norway.
(author)
-
Skovlund, Charlotte WesselDanish Canc Soc Res Ctr, Danish Canc Soc, Canc Surveillance & Pharmacoepidemiol, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.
(author)
-
Morch, Lina SteinrudDanish Canc Soc Res Ctr, Danish Canc Soc, Canc Surveillance & Pharmacoepidemiol, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.
(author)
-
Friis, SorenDanish Canc Soc Res Ctr, Danish Canc Soc, Canc Surveillance & Pharmacoepidemiol, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.
(author)
-
Gamborg, MadsDanish Canc Soc Res Ctr, Danish Canc Soc, Canc Surveillance & Pharmacoepidemiol, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.
(author)
-
Kristiansen, Marnar FrioheimFac Hlth Sci, Ctr Hlth Sci, Torshavn, Faroe Islands.;Natl Hosp Faroe Isl, Torshavn, Faroe Islands.
(author)
-
Pettersson, DavidNatl Board Hlth & Welf, SE-10630 Stockholm, Sweden.
(author)
-
Olafsdottir, Elinborg J.Iceland Canc Soc, ICS Res & Registrat Ctr, POB 5420, IS-105 Reykjavik, Iceland.
(author)
-
Birgisson, HelgiIceland Canc Soc, ICS Res & Registrat Ctr, POB 5420, IS-105 Reykjavik, Iceland.
(author)
-
Palsson, RunolfurLandspitali The Natl Univ Hosp Iceland, Saemundargata 2, IS-102 Reykjavik, Iceland.;Univ Iceland, Reykjavik, Iceland.
(author)
-
Eythorsson, EliasLandspitali The Natl Univ Hosp Iceland, Saemundargata 2, IS-102 Reykjavik, Iceland.
(author)
-
Irenaeus, SandraUppsala universitet,Cancerimmunterapi,Akadem Sjukhuset, Reg Canc Ctr Cent Sweden, SE-75185 Uppsala, Sweden.(Swepub:uu)sanir765
(author)
-
Lambe, MatsKarolinska Inst, Dept Med Epidemiol & Biostat, POB 281, SE-17177 Stockholm, Sweden.;Akadem Sjukhuset, Reg Canc Ctr Cent Sweden, SE-75185 Uppsala, Sweden.
(author)
-
Ursin, GiskeCanc Registry Norway, POB 5313 Majorstuen, N-0304 Oslo, Norway.;Univ Oslo, Inst Basic Med Sci, Oslo, Norway.;Univ Southern Calif, Dept Prevent Med, Los Angeles, CA USA.
(author)
-
Karolinska InstitutetCanc Registry Norway, POB 5313 Majorstuen, N-0304 Oslo, Norway.;Karolinska Inst, Dept Med Epidemiol & Biostat, POB 281, SE-17177 Stockholm, Sweden.
(creator_code:org_t)
Related titles
-
In:The Lancet Regional Health: Elsevier312666-7762
Internet link
Find in a library
To the university's database
- By the author/editor
-
Johansson, Anna ...
-
Skog, Anna
-
Johannesen, Tom ...
-
Myklebust, Tor a ...
-
Skovlund, Charlo ...
-
Morch, Lina Stei ...
-
show more...
-
Friis, Soren
-
Gamborg, Mads
-
Kristiansen, Mar ...
-
Pettersson, Davi ...
-
Olafsdottir, Eli ...
-
Birgisson, Helgi
-
Palsson, Runolfu ...
-
Eythorsson, Elia ...
-
Irenaeus, Sandra
-
Lambe, Mats
-
Ursin, Giske
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Cancer and Oncol ...
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Infectious Medic ...
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Health Sciences
-
and Public Health Gl ...
- Articles in the publication
-
The Lancet Regio ...
- By the university
-
Uppsala University
-
Karolinska Institutet